Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changming Yu

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Clinical and Vaccine Immunology : CVI|August 5, 2011
A conformational change of C fragment of tetanus neurotoxin reduces its ganglioside-binding activity but does not destroy its immunogenicityRui Yu, Shaoqiong Yi, Changming Yu, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|January 9, 2013
[Construction and expression of recombinant prokaryotic expression vector for disulfide-stabilized anti-TeNT single-chain Fv antibody]Han Wang, Rui Yu, Xiaopeng Zhang, et al.
Toxins|June 28, 2016
Comparative Immunogenicity of the Tetanus Toxoid and Recombinant Tetanus Vaccines in Mice, Rats, and Cynomolgus MonkeysRui Yu, Ting Fang, Shuling Liu, et al.
Plos One|December 25, 2015
Identification and Functional Characterization of Glycosylation of Recombinant Human Platelet-Derived Growth Factor-BB in Pichia pastorisMengmeng Dai, Changming Yu, Ting Fang, et al.
Frontiers in Microbiology|March 17, 2023
An adenovirus-vectored RVF vaccine confers complete protection against lethal RVFV challenge in A129 miceMeng Hao, Ting Bian, Guangcheng Fu, et al.
Current Issues in Molecular Biology|July 29, 2025
Characterization of an mRNA-Encoded Antibody Against HenipavirusZixuan Liu, Bingjie Sun, Ting Fang, et al.
Frontiers in Immunology|November 28, 2022
Single-dose of a replication-competent adenovirus-vectored vaccine provides sterilizing protection against Rift Valley fever virus challengeTing Bian, Busen Wang, Guangcheng Fu, et al.
Antiviral Research|June 18, 2014
PEGylated recombinant human interferon-ω as a long-acting antiviral agent: structure, antiviral activity and pharmacokineticsWeili Yu, Changming Yu, Ling Wu, et al.
Microbiology Spectrum|August 29, 2025
Bispecific antibody engineered from two non-protective antibodies confers full protection against anthrax toxin through inhibition of PA83 cleavageZhengshan Chen, Guanying Zhang, Jin Han, et al.
FEBS Letters|April 1, 2009
Fusion protein of Delta 27LFn and EFn has the potential as a novel anthrax toxin inhibitorYirong Kong, Qiang Guo, Changming Yu, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Clinical and Vaccine Immunology : CVI|August 5, 2011
A conformational change of C fragment of tetanus neurotoxin reduces its ganglioside-binding activity but does not destroy its immunogenicityRui Yu, Shaoqiong Yi, Changming Yu, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|January 9, 2013
[Construction and expression of recombinant prokaryotic expression vector for disulfide-stabilized anti-TeNT single-chain Fv antibody]Han Wang, Rui Yu, Xiaopeng Zhang, et al.
Toxins|June 28, 2016
Comparative Immunogenicity of the Tetanus Toxoid and Recombinant Tetanus Vaccines in Mice, Rats, and Cynomolgus MonkeysRui Yu, Ting Fang, Shuling Liu, et al.
Plos One|December 25, 2015
Identification and Functional Characterization of Glycosylation of Recombinant Human Platelet-Derived Growth Factor-BB in Pichia pastorisMengmeng Dai, Changming Yu, Ting Fang, et al.
Frontiers in Microbiology|March 17, 2023
An adenovirus-vectored RVF vaccine confers complete protection against lethal RVFV challenge in A129 miceMeng Hao, Ting Bian, Guangcheng Fu, et al.
Current Issues in Molecular Biology|July 29, 2025
Characterization of an mRNA-Encoded Antibody Against HenipavirusZixuan Liu, Bingjie Sun, Ting Fang, et al.
Frontiers in Immunology|November 28, 2022
Single-dose of a replication-competent adenovirus-vectored vaccine provides sterilizing protection against Rift Valley fever virus challengeTing Bian, Busen Wang, Guangcheng Fu, et al.
Antiviral Research|June 18, 2014
PEGylated recombinant human interferon-ω as a long-acting antiviral agent: structure, antiviral activity and pharmacokineticsWeili Yu, Changming Yu, Ling Wu, et al.
Microbiology Spectrum|August 29, 2025
Bispecific antibody engineered from two non-protective antibodies confers full protection against anthrax toxin through inhibition of PA83 cleavageZhengshan Chen, Guanying Zhang, Jin Han, et al.
FEBS Letters|April 1, 2009
Fusion protein of Delta 27LFn and EFn has the potential as a novel anthrax toxin inhibitorYirong Kong, Qiang Guo, Changming Yu, et al.
Pageof 6